SCHEMBL20867100

SCHEMBL20867100

N=C(ON)c1cc(C(F)(F)F)sc1N1CCOCC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.36
▸ POLB P06746 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ ALDH1A1 P00352 4/20 0.35
▸ LMNA P02545 1/20 0.35
▸ PRKDC P78527 3/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ AOC3 Q16853 1/20 0.30
▸ ALOX15 P16050 1/20 0.30
▸ MEN1 O00255 2/20 0.30
▸ KMT2A Q03164 2/20 0.30
▸ MAPT P10636 1/20 0.30
▸ HPGD P15428 1/20 0.30
▸ TDP1 Q9NUW8 1/20 0.30
▸ MTOR P42345 5/20 0.30
▸ PIK3CA P42336 4/20 0.30
▸ PIK3CB P42338 3/20 0.30
▸ SMN1; SMN2 Q16637 2/20 0.30
▸ PIK3CD O00329 2/20 0.30
▸ PIK3C2B O00750 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18412857 0.77 ALDH1A1 (0.48) KDM4EPOLBNPSR1ALDH1A1LMNA
SCHEMBL18395227 0.76 KDM4E (0.45) KDM4EPOLBNPSR1ALDH1A1PRKDC
SCHEMBL20867101 0.73 ALDH1A1 (0.56) KDM4EPOLBNPSR1ALDH1A1LMNA
SCHEMBL20866838 0.68 ATM (0.32) KDM4EALDH1A1LMNAAOC3MAPT
SCHEMBL20867306 0.67 ATM (0.31) LMNAAOC3
SCHEMBL20369884 0.67 ALDH1A1 (0.57) KDM4EPOLBALDH1A1LMNAHSD17B10
SCHEMBL20867213 0.66 KCNH2 (0.40) KDM4ENPSR1HSD17B10AOC3HPGD
SCHEMBL20866886 0.65 PRKDC (0.45) LMNAPRKDCMEN1KMT2AMAPT
SCHEMBL20867295 0.65 — —
SCHEMBL24612210 0.63 FBP1 (0.31) KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019067864-A1 COMBINATION PHARMACEUTICAL AGENTS AS RSV INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2019-04-04 — — WO disclosed
Send feedback